Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 5
1950 1
1951 5
1952 1
1953 2
1954 2
1955 4
1956 4
1957 1
1959 1
1962 1
1963 1
1964 1
1965 2
1966 2
1967 4
1968 2
1969 1
1970 2
1971 1
1973 5
1974 15
1975 4
1976 3
1977 2
1978 5
1979 4
1980 4
1982 6
1983 4
1984 4
1985 1
1987 4
1989 3
1990 3
1991 1
1992 3
1993 2
1994 1
1995 1
1996 5
1997 4
1998 9
1999 6
2000 11
2001 9
2002 16
2003 10
2004 17
2005 17
2006 13
2007 8
2008 13
2009 13
2010 23
2011 13
2012 13
2013 14
2014 15
2015 16
2016 28
2017 12
2018 15
2019 27
2020 32
2021 41
2022 33
2023 27
2024 25
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

567 results

Results by year

Filters applied: . Clear all
Page 1
Prioritization in inflammatory bowel disease therapy.
Herrlinger KR, Stange EF. Herrlinger KR, et al. Expert Rev Gastroenterol Hepatol. 2023 Jul-Dec;17(8):753-767. doi: 10.1080/17474124.2023.2240699. Epub 2023 Jul 26. Expert Rev Gastroenterol Hepatol. 2023. PMID: 37480322 Review.
Inflammatory Bowel Disease.
Wehkamp J, Götz M, Herrlinger K, Steurer W, Stange EF. Wehkamp J, et al. Dtsch Arztebl Int. 2016 Feb 5;113(5):72-82. doi: 10.3238/arztebl.2016.0072. Dtsch Arztebl Int. 2016. PMID: 26900160 Free PMC article. Review.
Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.1) – Februar 2023 – AWMF-Registriernummer: 021-009.
Kucharzik T, Dignass A, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengiesser K, Kienle P, Langhorst J, Lügering A, Schreiber S, Stallmach A, Stein J, Sturm A, Teich N, Siegmund B; Collaborators:. Kucharzik T, et al. Z Gastroenterol. 2023 Aug;61(8):1046-1134. doi: 10.1055/a-2060-0935. Epub 2023 Aug 14. Z Gastroenterol. 2023. PMID: 37579791 Free article. German. No abstract available.
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, Kortmann RD, Krex D, Grauer O, Goldbrunner R, Schnell O, Bähr O, Uhl M, Seidel C, Tabatabai G, Kowalski T, Ringel F, Schmidt-Graf F, Suchorska B, Brehmer S, Weyerbrock A, Renovanz M, Bullinger L, Galldiks N, Vajkoczy P, Misch M, Vatter H, Stuplich M, Schäfer N, Kebir S, Weller J, Schaub C, Stummer W, Tonn JC, Simon M, Keil VC, Nelles M, Urbach H, Coenen M, Wick W, Weller M, Fimmers R, Schmid M, Hattingen E, Pietsch T, Coch C, Glas M; Neurooncology Working Group of the German Cancer Society. Herrlinger U, et al. Lancet. 2019 Feb 16;393(10172):678-688. doi: 10.1016/S0140-6736(18)31791-4. Epub 2019 Feb 14. Lancet. 2019. PMID: 30782343 Free article. Clinical Trial.
Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2).
Kucharzik T, Dignass A, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengiesser K, Kienle P, Langhorst J, Lügering A, Schreiber S, Stallmach A, Stein J, Sturm A, Teich N, Siegmund B; Collaborators. Kucharzik T, et al. Z Gastroenterol. 2024 May;62(5):769-858. doi: 10.1055/a-2271-0994. Epub 2024 May 8. Z Gastroenterol. 2024. PMID: 38718808 Free article. German. No abstract available.
Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline.
Sturm A, Atreya R, Bettenworth D, Bokemeyer B, Dignass A, Ehehalt R, Germer CT, Grunert PC, Helwig U, Horisberger K, Herrlinger K, Kienle P, Kucharzik T, Langhorst J, Maaser C, Ockenga J, Ott C, Siegmund B, Zeißig S, Stallmach A; Collaborators. Sturm A, et al. Z Gastroenterol. 2024 Aug;62(8):1229-1318. doi: 10.1055/a-2309-6123. Epub 2024 Aug 7. Z Gastroenterol. 2024. PMID: 39111333 Free article. German. No abstract available.
Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004.
Sturm A, Atreya R, Bettenworth D, Bokemeyer B, Dignaß A, Ehehalt R, Germer C, Grunert PC, Helwig U, Herrlinger K, Kienle P, Kreis ME, Kucharzik T, Langhorst J, Maaser C, Ockenga J, Ott C, Siegmund B, Zeißig S, Stallmach A; Collaborators:. Sturm A, et al. Z Gastroenterol. 2022 Mar;60(3):332-418. doi: 10.1055/a-1713-3941. Epub 2022 Mar 9. Z Gastroenterol. 2022. PMID: 35263784 German. No abstract available.
Disconnecting multicellular networks in brain tumours.
Venkataramani V, Schneider M, Giordano FA, Kuner T, Wick W, Herrlinger U, Winkler F. Venkataramani V, et al. Nat Rev Cancer. 2022 Aug;22(8):481-491. doi: 10.1038/s41568-022-00475-0. Epub 2022 Apr 29. Nat Rev Cancer. 2022. PMID: 35488036 Review.
In Reply.
Wehkamp J, Götz M, Herrlinger K, Steurer W, Stange EF. Wehkamp J, et al. Dtsch Arztebl Int. 2016 Jul 1;113(26):462. doi: 10.3238/arztebl.2016.0462b. Dtsch Arztebl Int. 2016. PMID: 27412995 Free PMC article. No abstract available.
Aktualisierte S3-Leitlinie Colitis ulcerosa – Living Guideline.
Kucharzik T, Dignass AU, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengießer K, Kienle P, Langhorst J, Lügering A, Schreiber S, Stallmach A, Stein J, Sturm A, Teich N, Siegmund B; Collaborators:. Kucharzik T, et al. Z Gastroenterol. 2020 Dec;58(12):e241-e326. doi: 10.1055/a-1296-3444. Epub 2020 Dec 1. Z Gastroenterol. 2020. PMID: 33260237 German. No abstract available.
567 results